IGF2/H19 hypomethylation in a patient with very low birthweight, preocious pubarche and insulin resistance

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Murphy, Rinki ^a   Ibáñez, Lourdes ^b   Hattersley, Andrew ^c   Tost, Jörg ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF BARCELONA   (Spain)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

Insulin like growth factor 2; Insulin resistance; Intrauterine growth restriction; Short stature

Indexed keywords

GLUCOSE; SOMATOMEDIN B;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CASE REPORT; CONTROLLED STUDY; DIET RESTRICTION; DNA METHYLATION; DOWN REGULATION; DYSPHONIA; FEMALE; GENE MUTATION; GENE SEQUENCE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KARYOTYPING; MOLECULAR MECHANICS; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; PYROSEQUENCING; RETROGNATHIA; SHORT STATURE; VERY LOW BIRTH WEIGHT;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; DNA METHYLATION; DWARFISM; FEMALE; GENOMIC IMPRINTING; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR II; PHENOTYPE; PROGNOSIS; PUBERTY, PRECOCIOUS; RNA, LONG UNTRANSLATED; SILVER-RUSSELL SYNDROME; YOUNG ADULT;

MUS;

EID: 84861569839     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-42     Document Type: Article

References (32)

1. Weksberg R, et al. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 2003, 12(1):R61-R68. 10.1093/hmg/ddg067, 12668598.
2. Azzi S, et al. Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Hum Mol Genet 2009, 18(24):4724-4733. 10.1093/hmg/ddp435, 19755383.
3. Netchine I, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab 2007, 92(8):3148-3154. 10.1210/jc.2007-0354, 17504900.
4. Cui H, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003, 299(5613):1753-1755. 10.1126/science.1080902, 12637750.
5. Kaneda A, Feinberg AP. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Cancer Res 2005, 65(24):11236-11240. 10.1158/0008-5472.CAN-05-2959, 16357124.
6. Murrell A, Heeson S, Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nature Genetics 2004, 36(8):889-893. 10.1038/ng1402, 15273689.
7. Ito Y, et al. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet 2008, 17(17):2633-2643. 10.1093/hmg/ddn163, 2515372, 18541649.
8. Guo L, et al. Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Dev Biol 2008, 320(1):79-91. 10.1016/j.ydbio.2008.04.025, 18550048.
9. Gicquel C, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nature Genetics 2005, 37(9):1003-1007. 10.1038/ng1629, 16086014.
10. Engel N, et al. Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations. Nat Genet 2004, 36(8):883-888. 10.1038/ng1399, 15273688.
11. Abu-Amero S, et al. Epigenetic signatures of Silver-Russell syndrome. J Med Genet 2010, 47(3):150-154. 10.1136/jmg.2009.071316, 20305090.
12. Murrell A, et al. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer. PLoS One 2008, 3(3):e1849. 10.1371/journal.pone.0001849, 2268001, 18365005.
13. Bartholdi D, et al. Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes. J Med Genet 2009, 46(3):192-197.
14. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990, 345(6270):78-80. 10.1038/345078a0, 2330056.
15. Yakar S, Leroith D, Brodt P. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev 2005, 16(4-5):407-420.
16. Fisher A, et al. Duplications of chromosome 11p15 of maternal origin result in a phenotype that includes growth retardation. Hum Genet 2002, 111:290-296. 10.1007/s00439-002-0787-2, 12215843.
17. Eggermann T, et al. Is maternal duplication of 11p15 associated with Silver-Russell syndrome?. J Med Genet 2005, 42(5):e26. 10.1136/jmg.2004.028936, 1736048, 15863658.
18. Murphy R, et al. Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene. J Clin Endocrinol Metab 2008, 93(11):4373-4380. 10.1210/jc.2008-0819, 18728168.
19. Ibanez L, et al. Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev Endocr Metab Disord 2009, 10(1):63-76. 10.1007/s11154-008-9096-y, 18726694.
20. Ibanez L, et al. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 2004, 89(9):4331-4337. 10.1210/jc.2004-0463, 15356029.
21. Knight B, Shields BM, Hattersley AT. The Exeter Family Study of Childhood Health (EFSOCH): study protocol and methodology. Paediatr Perinat Epidemiol 2006, 20(2):172-179. 10.1111/j.1365-3016.2006.00701.x, 16466435.
22. Ferrandez-Longas A, et al. Estudio longitudinal de crecimiento y desarrollo. Patrones de crecimiento y desarrollo en España. Atlas de gráficas y tablas 2004, 61-115. ERGON, Madrid, Garcia-Dihinx A, Romo A, Ferrandez-Longas A.
23. Ibanez L, et al. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr 2004, 144(1):23-29. 10.1016/j.jpeds.2003.08.015, 14722514.
24. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007, 2(9):2265-2275. 10.1038/nprot.2007.314, 17853883.
25. Dejeux E, et al. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression. Endocr Relat Cancer 2009, 16(3):939-952. 10.1677/ERC-08-0331, 19502451.
26. Carrascosa A, et al. [Secular growth changes. Weight, height and body mass index values in infant, children, adolescent and young adults from Barcelona population]. Med Clin (Barc) 2004, 123(12):445-451.
27. Schonherr N, et al. (Epi)mutations in 11p15 significantly contribute to Silver-Russell syndrome: but are they generally involved in growth retardation?. Eur J Med Genet 2006, 49(5):414-418. 10.1016/j.ejmg.2006.03.001, 16603426.
28. Bruce S, et al. Clinically distinct epigenetic subgroups in Silver-Russell syndrome: the degree of H19 hypomethylation associates with phenotype severity and genital and skeletal anomalies. J Clin Endocrinol Metab 2009, 94(2):579-587. 10.1210/jc.2008-1805, 19017756.
29. Bliek J, et al. Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am J Hum Genet 2006, 78(4):604-614. 10.1086/502981, 1424698, 16532391.
30. Zeschnigk M, et al. IGF2/H19 hypomethylation in Silver-Russell syndrome and isolated hemihypoplasia. Eur J Hum Genet 2008, 16(3):328-334. 10.1038/sj.ejhg.5201974, 18159214.
31. Eggermann T, et al. Broad clinical spectrum in Silver-Russell syndrome and consequences for genetic testing in growth retardation. Pediatrics 2009, 123(5):e929-e931. 10.1542/peds.2008-3228, 19364767.
32. Obermann C. Searching for genomic variants in IGF2 and CDKN1C in Silver-Russell syndrome patients. Mol Genet Metab 2004, 82:246-250. 10.1016/j.ymgme.2004.04.008, 15234339.